Metabolic syndrome associated with hyperprolactinemia: A new indication for dopamine agonist treatment?

被引：9
作者：
Bernabeu, Ignacio [1 ,2 ]
Casanueva, Felipe F. [1 ,2 ]
机构：
[1] Complejo Hosp Univ Santiago CHUS, Inst Invest Sanitaria Santiago de Compostela IDIS, Div Endocrinol, Santiago De Compostela, Spain
[2] Univ Santiago de Compostela, Inst Salud Carlos III, Dept Med, CIBER Fisiopatol Obesidad & Nutr CB06 03, Santiago De Compostela, Spain
来源：
ENDOCRINE | 2013年 / 44卷 / 02期
关键词：
PROLACTIN; CABERGOLINE; RISK;
D O I：
10.1007/s12020-013-9914-1
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：273 / 274
页数：2
相关论文
共 13 条
  • [1] Focus on prolactin as a metabolic hormone
    Ben-Jonathan, N
    Hugo, ER
    Brandebourg, TD
    LaPensee, CR
    [J]. TRENDS IN ENDOCRINOLOGY AND METABOLISM, 2006, 17 (03) : 110 - 116
  • [2] What can we learn from rodents about prolactin in humans?
    Ben-Jonathan, Nira
    LaPensee, Christopher R.
    LaPensee, Elizabeth W.
    [J]. ENDOCRINE REVIEWS, 2008, 29 (01) : 1 - 41
  • [3] Insulin sensitivity and lipid profile in prolactinoma patients before and after normalization of prolactin by dopamine agonist therapy
    Berinder, Katarina
    Nystrom, Thomas
    Hoybye, Charlotte
    Hall, Kerstin
    Hulting, Anna-Lena
    [J]. PITUITARY, 2011, 14 (03) : 199 - 207
  • [4] Adipocyte prolactin: regulation of release and putative functions
    Brandebourg, T.
    Hugo, E.
    Ben-Jonathan, N.
    [J]. DIABETES OBESITY & METABOLISM, 2007, 9 (04) : 464 - 476
  • [5] Prolactin Levels, Endothelial Dysfunction, and the Risk of Cardiovascular Events and Mortality in Patients with CKD
    Carrero, Juan Jesus
    Kyriazis, John
    Sonmez, Alper
    Tzanakis, Ioannis
    Qureshi, Abdul Rashid
    Stenvinkel, Peter
    Saglam, Mutlu
    Stylianou, Kostas
    Yaman, Halil
    Taslipinar, Abdullah
    Vural, Abdulgaffar
    Gok, Mahmut
    Yenicesu, Mujdat
    Daphnis, Eugene
    Yilmaz, Mahmut Ilker
    [J]. CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2012, 7 (02): : 207 - 215
  • [6] Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas
    Casanueva, Felipe F.
    Molitch, Mark E.
    Schlechte, Janet A.
    Abs, Roger
    Bonert, Vivien
    Bronstein, Marcello D.
    Brue, Thierry
    Cappabianca, Paolo
    Colao, Annamaria
    Fahlbusch, Rudolf
    Fideleff, Hugo
    Hadani, Moshe
    Kelly, Paul
    Kleinberg, David
    Laws, Edward
    Marek, Josef
    Scanlon, Maurice
    Sobrinho, Luis G.
    Wass, John A. H.
    Giustina, Andrea
    [J]. CLINICAL ENDOCRINOLOGY, 2006, 65 (02) : 265 - 273
  • [7] The roles of prolactin, growth hormone, insulin-like growth factor-I, and thyroid hormones in lymphocyte development and function: Insights from genetic models of hormone and hormone receptor deficiency
    Dorshkind, K
    Horseman, ND
    [J]. ENDOCRINE REVIEWS, 2000, 21 (03) : 292 - 312
  • [8] BMI and Metabolic Profile in Patients With Prolactinoma Before and After Treatment With Dopamine Agonists
    dos Santos Silva, Cintia M.
    Barbosa, Flavia R. P.
    Lima, Giovanna A. B.
    Warszawski, Leila
    Fontes, Rosita
    Domingues, Romeu C.
    Gadelha, Monica R.
    [J]. OBESITY, 2011, 19 (04) : 800 - 805
  • [9] Positive association of serum prolactin concentrations with all-cause and cardiovascular mortality
    Haring, Robin
    Friedrich, Nele
    Voelzke, Henry
    Vasan, Ramachandran S.
    Felix, Stephan B.
    Doerr, Marcus
    Schwabedissen, Henriette E. Meyer Zu
    Nauck, Matthias
    Wallaschofski, Henri
    [J]. EUROPEAN HEART JOURNAL, 2014, 35 (18) : 1215 - U55
  • [10] Effect of cabergoline on insulin sensitivity, inflammation, and carotid intima media thickness in patients with prolactinoma
    Inancli, Serap Soytac
    Usluogullari, Alper
    Ustu, Yusuf
    Caner, Sedat
    Tam, Abbas Ali
    Ersoy, Reyhan
    Cakir, Bekir
    [J]. ENDOCRINE, 2013, 44 (01) : 193 - 199
12